Point72 Asset Management L.P. purchased a new stake in GoHealth, Inc. (NASDAQ:GOCO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 50,380 shares of the company's stock, valued at approximately $675,000. Point72 Asset Management L.P. owned approximately 0.22% of GoHealth at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Citadel Advisors LLC acquired a new position in shares of GoHealth during the fourth quarter valued at about $664,000. Ancora Advisors LLC acquired a new position in shares of GoHealth during the fourth quarter valued at about $408,000. Russell Investments Group Ltd. grew its holdings in shares of GoHealth by 41,225.5% during the fourth quarter. Russell Investments Group Ltd. now owns 21,076 shares of the company's stock valued at $282,000 after buying an additional 21,025 shares during the last quarter. Millennium Management LLC acquired a new position in shares of GoHealth during the fourth quarter valued at about $144,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of GoHealth by 103.8% during the fourth quarter. JPMorgan Chase & Co. now owns 17,195 shares of the company's stock valued at $230,000 after buying an additional 8,758 shares during the last quarter. 24.21% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada reiterated a "sector perform" rating and set a $18.00 price objective on shares of GoHealth in a report on Monday, May 19th.
Get Our Latest Research Report on GoHealth
GoHealth Stock Up 9.8%
GoHealth stock traded up $0.57 during midday trading on Tuesday, hitting $6.32. 61,113 shares of the stock were exchanged, compared to its average volume of 41,169. GoHealth, Inc. has a 52-week low of $5.57 and a 52-week high of $21.00. The stock has a market capitalization of $145.32 million, a price-to-earnings ratio of -1.81 and a beta of 1.71. The business's 50-day moving average price is $9.84 and its 200-day moving average price is $12.66. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72.
GoHealth (NASDAQ:GOCO - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.21). GoHealth had a negative return on equity of 17.17% and a negative net margin of 4.32%. The firm had revenue of $220.97 million for the quarter, compared to analysts' expectations of $225.91 million. On average, research analysts expect that GoHealth, Inc. will post -5.5 EPS for the current fiscal year.
GoHealth Profile
(
Free Report)
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
Further Reading

Before you consider GoHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.
While GoHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.